Metraipolis › archive › dc_4bcfe8986b67

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study — Europe PMC PMID:42519797

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42519797
DOI
10.3389/fmed.2026.1866311
License (as archived)
solo-consultazione
Archived
2026-10-18T11:04:40.618Z
SHA-256 of the archived text
7374427ba582cef2c04ae0cc5cfc866ba4637e0b7f49ad2b00b9fd1ae53432cf
Stable URL of this page
https://metraipolis.com/documento/dc_4bcfe8986b67

How to cite

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study — Europe PMC PMID:42519797 — Europe PMC (en), https://europepmc.org/article/MED/42519797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bcfe8986b67 (Metraipolis archive dc_4bcfe8986b67, sha256 7374427ba582cef2c04ae0cc5cfc866ba4637e0b7f49ad2b00b9fd1ae53432cf)
BibTeX
@misc{dc4bcfe8986b67,
  title = {Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study — Europe PMC PMID:42519797},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42519797},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bcfe8986b67; sha256 7374427ba582cef2c04ae0cc5cfc866ba4637e0b7f49ad2b00b9fd1ae53432cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42519797. Agents can read the archived copy with the MCP tool read_document.